Replies to post #333840 on Anavex Life Sciences Corp (AVXL)

[Talon38]

Falconer....you are right, the competition is making all the wrong moves with Biogen and Lilly chasing after the "flat earth" theory of amyloid plaque, SAVA and ANVS facing taxing investor legal action, CRTX down over $100 since Aug 8th and now Novartis finally throwing in the towel on AVXS-201.....we are "rounding the turn" with quite a lead. Missling is not even using the whip! The data in 2022 will keep us in the lead and the roar of the crowd is in the final stretch.

----

https://www.fiercebiotech.com/biotech/novartis-dumps-rett-gene-therapy-caught-up-zolgensma-scandal-cull-pipeline-prospects?oly_enc_id=6344A1822112C6Z

[frrol]

Biotech is not a horse race, zero sum game, or any other nonsense. If our drug proves therapeutic and safe, it will get regulatory approval.p and it will be terrific. It will not be magically superior nor exclusive to any and all other experimental therapies. Reality doesn't work that way.